<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37296623</PMID><DateCompleted><Year>2023</Year><Month>06</Month><Day>12</Day></DateCompleted><DateRevised><Year>2023</Year><Month>06</Month><Day>12</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2073-4409</ISSN><JournalIssue CitedMedium="Internet"><Volume>12</Volume><Issue>11</Issue><PubDate><Year>2023</Year><Month>May</Month><Day>29</Day></PubDate></JournalIssue><Title>Cells</Title><ISOAbbreviation>Cells</ISOAbbreviation></Journal><ArticleTitle>Restoring Axonal Organelle Motility and Regeneration in Cultured FUS-ALS Motoneurons through Magnetic Field Stimulation Suggests an Alternative Therapeutic Approach.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">1502</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/cells12111502</ELocationID><Abstract><AbstractText>Amyotrophic lateral sclerosis (ALS) is a devastating motoneuron disease characterized by sustained loss of neuromuscular junctions, degenerating corticospinal motoneurons and rapidly progressing muscle paralysis. Motoneurons have unique features, essentially a highly polarized, lengthy architecture of axons, posing a considerable challenge for maintaining long-range trafficking routes for organelles, cargo, mRNA and secretion with a high energy effort to serve crucial neuronal functions. Impaired intracellular pathways implicated in ALS pathology comprise RNA metabolism, cytoplasmic protein aggregation, cytoskeletal integrity for organelle trafficking and maintenance of mitochondrial morphology and function, cumulatively leading to neurodegeneration. Current drug treatments only have marginal effects on survival, thereby calling for alternative ALS therapies. Exposure to magnetic fields, e.g., transcranial magnetic stimulations (TMS) on the central nervous system (CNS), has been broadly explored over the past 20 years to investigate and improve physical and mental activities through stimulated excitability as well as neuronal plasticity. However, studies of magnetic treatments on the peripheral nervous system are still scarce. Thus, we investigated the therapeutic potential of low frequency alternating current magnetic fields on cultured spinal motoneurons derived from induced pluripotent stem cells of FUS-ALS patients and healthy persons. We report a remarkable restoration induced by magnetic stimulation on axonal trafficking of mitochondria and lysosomes and axonal regenerative sprouting after axotomy in FUS-ALS in vitro without obvious harmful effects on diseased and healthy neurons. These beneficial effects seem to derive from improved microtubule integrity. Thus, our study suggests the therapeutic potential of magnetic stimulations in ALS, which awaits further exploration and validation in future long-term in vivo studies.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kandhavivorn</LastName><ForeName>Wonphorn</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Dresden High Magnetic Field Laboratory (HLD-EMFL), Helmholtz-Zentrum Dresden-Rossendorf, D-01328 Dresden, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Anatomy, Technische Universit&#xe4;t Dresden, D-01307 Dresden, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gla&#xdf;</LastName><ForeName>Hannes</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0003-3155-5300</Identifier><AffiliationInfo><Affiliation>Division for Neurodegenerative Diseases, Department of Neurology, Technische Universit&#xe4;t Dresden, D-01307 Dresden, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Translational Neurodegeneration Section "Albrecht Kossel", Department of Neurology, University Medical Center Rostock, University of Rostock, D-18147 Rostock, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Herrmannsd&#xf6;rfer</LastName><ForeName>Thomas</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Dresden High Magnetic Field Laboratory (HLD-EMFL), Helmholtz-Zentrum Dresden-Rossendorf, D-01328 Dresden, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>B&#xf6;ckers</LastName><ForeName>Tobias M</ForeName><Initials>TM</Initials><Identifier Source="ORCID">0000-0002-1486-8535</Identifier><AffiliationInfo><Affiliation>Institute of Anatomy and Cell Biology, University of Ulm, D-89081 Ulm, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Deutsches Zentrum f&#xfc;r Neurodegenerative Erkrankungen (DZNE) Ulm, D-89081 Ulm, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Uhlarz</LastName><ForeName>Marc</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Dresden High Magnetic Field Laboratory (HLD-EMFL), Helmholtz-Zentrum Dresden-Rossendorf, D-01328 Dresden, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gronemann</LastName><ForeName>Jonas</ForeName><Initials>J</Initials><Identifier Source="ORCID">0009-0002-8413-3056</Identifier><AffiliationInfo><Affiliation>Dresden High Magnetic Field Laboratory (HLD-EMFL), Helmholtz-Zentrum Dresden-Rossendorf, D-01328 Dresden, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Funk</LastName><ForeName>Richard H W</ForeName><Initials>RHW</Initials><AffiliationInfo><Affiliation>Institute of Anatomy, Technische Universit&#xe4;t Dresden, D-01307 Dresden, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Dresden International University, D-01067 Dresden, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pietzsch</LastName><ForeName>Jens</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-1610-1493</Identifier><AffiliationInfo><Affiliation>Department of Radiopharmaceutical and Chemical Biology, Institute of Radiopharmaceutical Cancer Research, Helmholtz-Zentrum Dresden-Rossendorf, D-01328 Dresden, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Faculty of Chemistry and Food Chemistry, School of Science, Technische Universit&#xe4;t Dresden, D-01069 Dresden, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pal</LastName><ForeName>Arun</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Dresden High Magnetic Field Laboratory (HLD-EMFL), Helmholtz-Zentrum Dresden-Rossendorf, D-01328 Dresden, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division for Neurodegenerative Diseases, Department of Neurology, Technische Universit&#xe4;t Dresden, D-01307 Dresden, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hermann</LastName><ForeName>Andreas</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-7364-7791</Identifier><AffiliationInfo><Affiliation>Division for Neurodegenerative Diseases, Department of Neurology, Technische Universit&#xe4;t Dresden, D-01307 Dresden, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Translational Neurodegeneration Section "Albrecht Kossel", Department of Neurology, University Medical Center Rostock, University of Rostock, D-18147 Rostock, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Deutsches Zentrum f&#xfc;r Neurodegenerative Erkrankungen (DZNE) Rostock/Greifswald, D-18147 Rostock, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Transdisciplinary Neurosciences Rostock (CTNR), University Medical Center Rostock, University of Rostock, D-18147 Rostock, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>05</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Cells</MedlineTA><NlmUniqueID>101600052</NlmUniqueID><ISSNLinking>2073-4409</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000599550">FUS protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D034702">RNA-Binding Protein FUS</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009046" MajorTopicYN="N">Motor Neurons</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001369" MajorTopicYN="N">Axons</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015388" MajorTopicYN="N">Organelles</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D060526" MajorTopicYN="N">Magnetic Fields</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D034702" MajorTopicYN="N">RNA-Binding Protein FUS</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">AC electromagnetic stimulation</Keyword><Keyword MajorTopicYN="N">amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">axonal organelle trafficking</Keyword><Keyword MajorTopicYN="N">axonal regeneration</Keyword><Keyword MajorTopicYN="N">axonal sprouting</Keyword><Keyword MajorTopicYN="N">axonopathy</Keyword><Keyword MajorTopicYN="N">induced pluripotent stem cells</Keyword><Keyword MajorTopicYN="N">microtubules stabilization</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>3</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>5</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>5</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>6</Month><Day>12</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>6</Month><Day>10</Day><Hour>15</Hour><Minute>13</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>6</Month><Day>10</Day><Hour>1</Hour><Minute>1</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37296623</ArticleId><ArticleId IdType="pmc">PMC10252208</ArticleId><ArticleId IdType="doi">10.3390/cells12111502</ArticleId><ArticleId IdType="pii">cells12111502</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Cook C., Petrucelli L. Genetic Convergence Brings Clarity to the Enigmatic Red Line in ALS. Neuron. 2019;101:1057&#x2013;1069. doi: 10.1016/j.neuron.2019.02.032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2019.02.032</ArticleId><ArticleId IdType="pubmed">30897357</ArticleId></ArticleIdList></Reference><Reference><Citation>Peters O.M., Ghasemi M., Jr R.H.B. Emerging Mechanisms of Molecular Pathology in ALS Find the Latest Version: Emerging Mechanisms of Molecular Pathology in ALS. J. Clin. Investig. 2015;125:1767&#x2013;1779. doi: 10.1172/JCI71601.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI71601</ArticleId><ArticleId IdType="pmc">PMC4463186</ArticleId><ArticleId IdType="pubmed">25932674</ArticleId></ArticleIdList></Reference><Reference><Citation>Baeumer D., Hilton D., Paine S.M.L., Turner M.R., Lowe J., Talbot K., Ansorge O. Juvenile ALS with Basophilic Inclusions Is a FUS Proteinopathy with FUS Mutations. Neurology. 2010;75:611&#x2013;618. doi: 10.1212/WNL.0b013e3181ed9cde.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e3181ed9cde</ArticleId><ArticleId IdType="pmc">PMC2931770</ArticleId><ArticleId IdType="pubmed">20668261</ArticleId></ArticleIdList></Reference><Reference><Citation>Conte A., Lattante S., Zollino M., Marangi G., Luigetti M., Del Grande A., Servidei S., Trombetta F., Sabatelli M. P525L FUS Mutation Is Consistently Associated with a Severe Form of Juvenile Amyotrophic Lateral Sclerosis. Neuromuscul. Disord. 2012;22:73&#x2013;75. doi: 10.1016/j.nmd.2011.08.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nmd.2011.08.003</ArticleId><ArticleId IdType="pubmed">21907581</ArticleId></ArticleIdList></Reference><Reference><Citation>Naumann M., Peikert K., G&#xfc;nther R., van der Kooi A.J., Aronica E., H&#xfc;bers A., Danel V., Corcia P., Pan-Montojo F., Cirak S., et al. Phenotypes and Malignancy Risk of Different FUS Mutations in Genetic Amyotrophic Lateral Sclerosis. Ann. Clin. Transl. Neurol. 2019;6:2384&#x2013;2394. doi: 10.1002/acn3.50930.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acn3.50930</ArticleId><ArticleId IdType="pmc">PMC6917314</ArticleId><ArticleId IdType="pubmed">31682085</ArticleId></ArticleIdList></Reference><Reference><Citation>Grassano M., Brodini G., Marco G.D., Casale F., Fuda G., Salamone P., Brunetti M., Sbaiz L., Gallone S., Cugnasco P., et al. Phenotype Analysis of Fused in Sarcoma Mutations in Amyotrophic Lateral Sclerosis. Neurol. Genet. 2022;8:e200011. doi: 10.1212/NXG.0000000000200011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/NXG.0000000000200011</ArticleId><ArticleId IdType="pmc">PMC9469212</ArticleId><ArticleId IdType="pubmed">36105853</ArticleId></ArticleIdList></Reference><Reference><Citation>Giancarlo L., Marco P., Beno&#xee;t M., Emma N., Foad A.-A., Ahmed A., Fares A., Weldegebreal A.S., Ashish A., Yazan C., et al. Global, Regional, and National Burden of Motor Neuron Diseases 1990&#x2013;2016: A Systematic Analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2016;12:1083&#x2013;1097. doi: 10.1016/S1474-4422(18)30404-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(18)30404-6</ArticleId><ArticleId IdType="pmc">PMC6234315</ArticleId><ArticleId IdType="pubmed">30409709</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller R.G., Mitchell J.D., Lyon M., Moore D.H. Riluzole for Amyotrophic Lateral Sclerosis (ALS)/Motor Neuron Disease (MND) Cochrance Database Syst. Rev. 2002;4:191&#x2013;206. doi: 10.1002/14651858.CD001447.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858.CD001447</ArticleId><ArticleId IdType="pubmed">13129806</ArticleId></ArticleIdList></Reference><Reference><Citation>Abe K., Aoki M., Tsuji S., Itoyama Y., Sobue G., Togo M., Hamada C., Tanaka M., Akimoto M., Nakamura K., et al. Safety and Efficacy of Edaravone in Well Defined Patients with Amyotrophic Lateral Sclerosis: A Randomised, Double-Blind, Placebo-Controlled Trial. Lancet Neurol. 2017;16:505&#x2013;512. doi: 10.1016/S1474-4422(17)30115-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(17)30115-1</ArticleId><ArticleId IdType="pubmed">28522181</ArticleId></ArticleIdList></Reference><Reference><Citation>Witzel S., Maier A., Steinbach R., Grosskreutz J., Koch J.C., Sarikidi A., Petri S., G&#xfc;nther R., Wolf J., Hermann A., et al. Safety and Effectiveness of Long-Term Intravenous Administration of Edaravone for Treatment of Patients With Amyotrophic Lateral Sclerosis. JAMA Neurol. 2022;79:121&#x2013;130. doi: 10.1001/jamaneurol.2021.4893.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2021.4893</ArticleId><ArticleId IdType="pmc">PMC8749709</ArticleId><ArticleId IdType="pubmed">35006266</ArticleId></ArticleIdList></Reference><Reference><Citation>Taylor J.P., Brown R.H., Jr., Don W. Decoding ALS: From Genes to Mechanism. Nature. 2016;539:197&#x2013;206. doi: 10.1038/nature20413.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature20413</ArticleId><ArticleId IdType="pmc">PMC5585017</ArticleId><ArticleId IdType="pubmed">27830784</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng H., Gao K., Jankovic J. The Role of FUS Gene Variants in Neurodegenerative Diseases. Nat. Rev. Neurol. 2014;10:337&#x2013;348. doi: 10.1038/nrneurol.2014.78.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2014.78</ArticleId><ArticleId IdType="pubmed">24840975</ArticleId></ArticleIdList></Reference><Reference><Citation>Naumann M., Pal A., Goswami A., Lojewski X., Japtok J., Vehlow A., Naujock M., G&#xfc;nther R., Jin M., Stanslowsky N., et al. Impaired DNA Damage Response Signaling by FUS- NLS Mutations Leads to Neurodegeneration and FUS Aggregate Formation. Nat. Commun. 2018;9:335. doi: 10.1038/s41467-017-02299-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-017-02299-1</ArticleId><ArticleId IdType="pmc">PMC5780468</ArticleId><ArticleId IdType="pubmed">29362359</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo W., Naujock M., Fumagalli L., Vandoorne T., Baatsen P., Boon R., Ordov&#xe1;s L., Patel A., Welters M., Vanwelden T., et al. HDAC6 Inhibition Reverses Axonal Transport Defects in Motor Neurons Derived from FUS-ALS Patients. Nat. Commun. 2017;8:861. doi: 10.1038/s41467-017-00911-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-017-00911-y</ArticleId><ArticleId IdType="pmc">PMC5636840</ArticleId><ArticleId IdType="pubmed">29021520</ArticleId></ArticleIdList></Reference><Reference><Citation>Alhindi A., Boehm I., Chaytow H. Small Junction, Big Problems: Neuromuscular Junction Pathology in Mouse Models of Amyotrophic Lateral Sclerosis (ALS) J. Anat. 2021;241:1089&#x2013;1107. doi: 10.1111/joa.13463.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/joa.13463</ArticleId><ArticleId IdType="pmc">PMC9558162</ArticleId><ArticleId IdType="pubmed">34101196</ArticleId></ArticleIdList></Reference><Reference><Citation>Hallett M. Transcranial Magnetic Stimulation and the Human Brain. Nature. 2000;406:147&#x2013;150. doi: 10.1038/35018000.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/35018000</ArticleId><ArticleId IdType="pubmed">10910346</ArticleId></ArticleIdList></Reference><Reference><Citation>Petersen N.T., Pyndt H.S., Nielsen J.B. Investigating Human Motor Control by Transcranial Magnetic Stimulation. Exp. Brain Res. 2003;152:1&#x2013;16. doi: 10.1007/s00221-003-1537-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00221-003-1537-y</ArticleId><ArticleId IdType="pubmed">12879177</ArticleId></ArticleIdList></Reference><Reference><Citation>Fregni F., Pascual-leone A. Technology Insight: Noninvasive Brain Stimulation in Neurology&#x2014;Perspectives on the Therapeutic Potential of RTMS and TDCS. Nat. Publ. Group. 2007;3:383&#x2013;393. doi: 10.1038/ncpneuro0530.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncpneuro0530</ArticleId><ArticleId IdType="pubmed">17611487</ArticleId></ArticleIdList></Reference><Reference><Citation>St&#xf6;lting M.N.L., Arnold A.S., Haralampieva D., Handschin C., Sulser T., Eberli D. Magnetic Stimulation Supports Muscle and Nerve Regeneration after Trauma in Mice. Muscle Nerve. 2016;53:598&#x2013;607. doi: 10.1002/mus.24780.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.24780</ArticleId><ArticleId IdType="pmc">PMC5130145</ArticleId><ArticleId IdType="pubmed">26202157</ArticleId></ArticleIdList></Reference><Reference><Citation>Musar&#xf2; A., Dobrowolny G., Cambieri C., Onesti E., Ceccanti M., Frasca V., Pisano A., Cerbelli B., Lepore E., Ruffolo G., et al. Neuromuscular Magnetic Stimulation Counteracts Muscle Decline in ALS Patients: Results of a Randomized, Double-Blind, Controlled Study. Sci. Rep. 2019;9:2837. doi: 10.1038/s41598-019-39313-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-019-39313-z</ArticleId><ArticleId IdType="pmc">PMC6391419</ArticleId><ArticleId IdType="pubmed">30808899</ArticleId></ArticleIdList></Reference><Reference><Citation>Pal A., Kretner B., Abo-Rady M., Glab H., Dash B.P., Naumann M., Japtok J., Kreiter N., Dhingra A., Heutink P., et al. Concomitant Gain and Loss of Function Pathomechanisms in C9ORF72 Amyotrophic Lateral Sclerosis. Life Sci. Alliance. 2021;4:1&#x2013;26. doi: 10.26508/lsa.202000764.</Citation><ArticleIdList><ArticleId IdType="doi">10.26508/lsa.202000764</ArticleId><ArticleId IdType="pmc">PMC7918691</ArticleId><ArticleId IdType="pubmed">33619157</ArticleId></ArticleIdList></Reference><Reference><Citation>Bruneteau G., Bauch&#xe9; S., de Aguilar J.L.G., Brochier G., Mandjee N., Tanguy M.-L., Hussain G., Behin A., Khiami F., Sariali E., et al. Endplate Denervation Correlates with Nogo-A Muscle Expression in Amyotrophic Lateral Sclerosis Patients. Ann. Clin. Transl. Neurol. 2015;2:362&#x2013;372. doi: 10.1002/acn3.179.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acn3.179</ArticleId><ArticleId IdType="pmc">PMC4402082</ArticleId><ArticleId IdType="pubmed">25909082</ArticleId></ArticleIdList></Reference><Reference><Citation>Japtok J., Lojewksi X., Naumann M., Klingenstein M., Reinhardt P., Sterneckert J., Putz S., Demestre M., Boeckers T.M., Ludolph A.C., et al. Stepwise Acquirement of Hallmark Neuropathology in FUS-ALS IPSC Models Depends on Mutation Type and Neuronal Aging. Neurobiol. Dis. 2015;82:420&#x2013;429. doi: 10.1016/j.nbd.2015.07.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2015.07.017</ArticleId><ArticleId IdType="pubmed">26253605</ArticleId></ArticleIdList></Reference><Reference><Citation>Higelin J., Demestre M., Putz S., Delling J.P., Jacob C., Lutz A.K., Bausinger J., Huber A.K., Klingenstein M., Barbi G., et al. FUS Mislocalization and Vulnerability to DNA Damage in ALS Patients Derived HiPSCs and Aging Motoneurons. Front. Cell. Neurosci. 2016;10:290. doi: 10.3389/fncel.2016.00290.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2016.00290</ArticleId><ArticleId IdType="pmc">PMC5183648</ArticleId><ArticleId IdType="pubmed">28082870</ArticleId></ArticleIdList></Reference><Reference><Citation>Naujock M., Stanslowsky N., Bufler S., Naumann M., Reinhardt P., Sterneckert J., Ekaterini K., Carola K., Franziska B., Lojewski X., et al. 4-Aminopyridine Induced Activity Rescues Hypoexcitable Motor Neurons from Amyotrophic Lateral Sclerosis Patient-Derived Induced Pluripotent Stem Cells. Stem Cells. 2016;34:1563&#x2013;1575. doi: 10.1002/stem.2354.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/stem.2354</ArticleId><ArticleId IdType="pubmed">26946488</ArticleId></ArticleIdList></Reference><Reference><Citation>Reinhardt P., Glatza M., Hemmer K., Tsytsyura Y., Thiel C.S., H&#xf6;ing S., Moritz S., Parga J.A., Wagner L., Bruder J.M., et al. Derivation and Expansion Using Only Small Molecules of Human Neural Progenitors for Neurodegenerative Disease Modeling. PLoS ONE. 2013;8:e59252. doi: 10.1371/annotation/6a917a2e-df4a-4ad9-99bb-6aa7218b833e.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/annotation/6a917a2e-df4a-4ad9-99bb-6aa7218b833e</ArticleId><ArticleId IdType="pmc">PMC3606479</ArticleId><ArticleId IdType="pubmed">23533608</ArticleId></ArticleIdList></Reference><Reference><Citation>Pal A., Gla&#xdf; H., Naumann M., Kreiter N., Japtok J., Sczech R., Hermann A. High Content Organelle Trafficking Enables Disease State Profiling as Powerful Tool for Disease Modelling. Sci. Data. 2018;5:180241. doi: 10.1038/sdata.2018.241.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sdata.2018.241</ArticleId><ArticleId IdType="pmc">PMC6233479</ArticleId><ArticleId IdType="pubmed">30422121</ArticleId></ArticleIdList></Reference><Reference><Citation>Taylor A.M., Blurton-Jones M., Rhee S.W., Cribbs D.H., Cotman C.W., Jeon N.L. A Microfluidic Culture Platform for CNS Axonal Injury, Regeneration and Transport. Nat. Methods. 2005;2:599&#x2013;605. doi: 10.1038/nmeth777.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nmeth777</ArticleId><ArticleId IdType="pmc">PMC1558906</ArticleId><ArticleId IdType="pubmed">16094385</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsantoulas C., Farmer C., Machado P., Baba K., McMahon S.B., Raouf R. Probing Functional Properties of Nociceptive Axons Using a Microfluidic Culture System. PLoS ONE. 2013;8:e80722. doi: 10.1371/journal.pone.0080722.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0080722</ArticleId><ArticleId IdType="pmc">PMC3835735</ArticleId><ArticleId IdType="pubmed">24278311</ArticleId></ArticleIdList></Reference><Reference><Citation>Vysokov N., McMahon S.B., Raouf R. The Role of NaV Channels in Synaptic Transmission after Axotomy in a Microfluidic Culture Platform. Sci. Rep. 2019;9:12915. doi: 10.1038/s41598-019-49214-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-019-49214-w</ArticleId><ArticleId IdType="pmc">PMC6733904</ArticleId><ArticleId IdType="pubmed">31501450</ArticleId></ArticleIdList></Reference><Reference><Citation>Piacentini R., Ripoli C., Mezzogori D., Azzena G.B., Grassi C. Extremely Low-Frequency Electromagnetic Fields Promote In Vitro Neurogenesis Via Upregulation of Ca v 1-Channel Activity. J. Cell. Physiol. 2008;251:129&#x2013;139. doi: 10.1002/jcp.21293.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcp.21293</ArticleId><ArticleId IdType="pubmed">17941084</ArticleId></ArticleIdList></Reference><Reference><Citation>Maeder C.I., Shen K., Hoogenraad C.C. Axon and Dendritic Trafficking. Curr. Opin. Neurobiol. 2014;27:165&#x2013;170. doi: 10.1016/j.conb.2014.03.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.conb.2014.03.015</ArticleId><ArticleId IdType="pubmed">24762653</ArticleId></ArticleIdList></Reference><Reference><Citation>Pierre U. Axonal Transport Deficits and Neurodegenerative Diseases. Nat. Rev. Neurosci. 2013;14:161&#x2013;176. doi: 10.1038/nrn3380.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrn3380</ArticleId><ArticleId IdType="pubmed">23361386</ArticleId></ArticleIdList></Reference><Reference><Citation>Gla&#xdf; H., Neumann P., Pal A., Reinhardt P., Storch A., Sterneckert J., Hermann A. Combined Dendritic and Axonal Deterioration Are Responsible for Motoneuronopathy in Patient-Derived Neuronal Cell Models of Chorea-Acanthocytosis. Int. J. Mol. Sci. 2020;21:1797. doi: 10.3390/ijms21051797.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21051797</ArticleId><ArticleId IdType="pmc">PMC7084777</ArticleId><ArticleId IdType="pubmed">32151030</ArticleId></ArticleIdList></Reference><Reference><Citation>Mateos-aparicio P., Rodr&#xed;guez-moreno A. The Impact of Studying Brain Plasticity. Front. Cell. Neurosci. 2019;13:66. doi: 10.3389/fncel.2019.00066.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2019.00066</ArticleId><ArticleId IdType="pmc">PMC6400842</ArticleId><ArticleId IdType="pubmed">30873009</ArticleId></ArticleIdList></Reference><Reference><Citation>Burke S.N., Barnes C.A. Neural Plasticity in the Ageing Brain. Nature. 2006;7:30&#x2013;40. doi: 10.1038/nrn1809.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrn1809</ArticleId><ArticleId IdType="pubmed">16371948</ArticleId></ArticleIdList></Reference><Reference><Citation>Bradke F., Fawcett J.W., Spira M.E. Assembly of a New Growth Cone after Axotomy: The Precursor to Axon Regeneration. Nat. Rev. Neurosci. 2012;13:183&#x2013;193. doi: 10.1038/nrn3176.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrn3176</ArticleId><ArticleId IdType="pubmed">22334213</ArticleId></ArticleIdList></Reference><Reference><Citation>Alvarez F.J., Rotterman T.M., Akhter E.T., Lane A.R., English A.W., Cope T.C. Synaptic Plasticity on Motoneurons After Axotomy: A Necessary Change in Paradigm. Front. Mol. Neurosci. 2020;13:68. doi: 10.3389/fnmol.2020.00068.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2020.00068</ArticleId><ArticleId IdType="pmc">PMC7203341</ArticleId><ArticleId IdType="pubmed">32425754</ArticleId></ArticleIdList></Reference><Reference><Citation>Groen E.J.N., Fumoto K., Blokhuis A.M., Engelen-lee J., Heuvel D.M.A.V.D., Koppers M., Diggelen F.V., Heest J.V., Demmers J.A.A., Kirby J., et al. ALS-Associated Mutations in FUS Disrupt the Axonal Distribution and Function of SMN. Hum. Mol. Genet. 2013;22:3690&#x2013;3704. doi: 10.1093/hmg/ddt222.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddt222</ArticleId><ArticleId IdType="pubmed">23681068</ArticleId></ArticleIdList></Reference><Reference><Citation>Chapin S.J., Bulinski J.C., Gundersen G. Microtubule Bundling in Cells. Nature. 1991;349:24. doi: 10.1038/349024a0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/349024a0</ArticleId><ArticleId IdType="pubmed">1670738</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu Z., Schaedel L., Portran D., Aguilar A., Gaillard J., Marinkovich M.P., Th&#xe9;ry M., Nachury M.V. Microtubules Acquire Resistance from Mechanical Breakage through Intralumenal Acetylation. Science. 2017;356:328&#x2013;332. doi: 10.1126/science.aai8764.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aai8764</ArticleId><ArticleId IdType="pmc">PMC5457157</ArticleId><ArticleId IdType="pubmed">28428427</ArticleId></ArticleIdList></Reference><Reference><Citation>Janke C., Montagnac G. Causes and Consequences of Microtubule Acetylation. Curr. Biol. 2017;27:R1287&#x2013;R1292. doi: 10.1016/j.cub.2017.10.044.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cub.2017.10.044</ArticleId><ArticleId IdType="pubmed">29207274</ArticleId></ArticleIdList></Reference><Reference><Citation>Bozzo F., Mirra A., Carr&#xec; M.T. Oxidative Stress and Mitochondrial Damage in the Pathogenesis of ALS: New Perspectives. Neurosci. Lett. 2017;636:3&#x2013;8. doi: 10.1016/j.neulet.2016.04.065.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neulet.2016.04.065</ArticleId><ArticleId IdType="pubmed">27150074</ArticleId></ArticleIdList></Reference><Reference><Citation>Burk K., Pasterkamp R.J. Disrupted Neuronal Trafficking in Amyotrophic Lateral Sclerosis. Acta Neuropathol. 2019;137:859&#x2013;877. doi: 10.1007/s00401-019-01964-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-019-01964-7</ArticleId><ArticleId IdType="pmc">PMC6531423</ArticleId><ArticleId IdType="pubmed">30721407</ArticleId></ArticleIdList></Reference><Reference><Citation>Kreiter N., Pal A., Lojewski X., Corcia P., Naujock M., Reinhardt P., Sterneckert J., Petri S., Wegner F., Storch A., et al. Age-Dependent Neurodegeneration and Organelle Transport Deficiencies in Mutant TDP43 Patient-Derived Neurons Are Independent of TDP43 Aggregation. Neurobiol. Dis. 2018;115:167&#x2013;181. doi: 10.1016/j.nbd.2018.03.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2018.03.010</ArticleId><ArticleId IdType="pubmed">29630989</ArticleId></ArticleIdList></Reference><Reference><Citation>Dis V.V., Kuijpers M., Haasdijk E.D., Teuling E., Oakes S.A., Hoogenraad C.C., Jaarsma D. Golgi Fragmentation Precedes Neuromuscular Denervation and Is Associated with Endosome Abnormalities in SOD1-ALS Mouse Motor Neurons. Acta Neuropathol. Commun. 2014;2:38. doi: 10.1186/2051-5960-2-38.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/2051-5960-2-38</ArticleId><ArticleId IdType="pmc">PMC4023628</ArticleId><ArticleId IdType="pubmed">24708899</ArticleId></ArticleIdList></Reference><Reference><Citation>Workman M.J., Lim R.G., Wu J., Frank A., Ornelas L., Panther L., Galvez E., Perez D., Meepe I., Lei S., et al. Large-Scale Differentiation of IPSC-Derived Motor Neurons from ALS and Control Subjects. Neuron. 2023;111:1191&#x2013;1204.e5. doi: 10.1016/j.neuron.2023.01.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2023.01.010</ArticleId><ArticleId IdType="pubmed">36764301</ArticleId></ArticleIdList></Reference><Reference><Citation>Campanari M., Ciura S. Neuromuscular Junction Impairment in Amyotrophic Lateral Sclerosis: Reassessing the Role of Acetylcholinesterase. Front. Mol. Neurosci. 2016;9:160. doi: 10.3389/fnmol.2016.00160.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2016.00160</ArticleId><ArticleId IdType="pmc">PMC5187284</ArticleId><ArticleId IdType="pubmed">28082868</ArticleId></ArticleIdList></Reference><Reference><Citation>Sivadasan R., Hornburg D., Drepper C., Frank N., Jablonka S., Hansel A., Lojewski X., Sterneckert J., Hermann A., Shaw P.J., et al. C9ORF72 Interaction with Cofilin Modulates Actin Dynamics in Motor Neurons. Nat. Neurosci. 2016;19:1610&#x2013;1618. doi: 10.1038/nn.4407.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.4407</ArticleId><ArticleId IdType="pubmed">27723745</ArticleId></ArticleIdList></Reference><Reference><Citation>So E., Mitchell J.C., Memmi C., Chennell G., Vizcay-barrena G., Allison L., Shaw C.E., Vance C. Mitochondrial Abnormalities and Disruption of the Neuromuscular Junction Precede the Clinical Phenotype and Motor Neuron Loss in HFUS WT Transgenic Mice. Hum. Mol. Genet. 2018;27:463&#x2013;474. doi: 10.1093/hmg/ddx415.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddx415</ArticleId><ArticleId IdType="pmc">PMC5886082</ArticleId><ArticleId IdType="pubmed">29194538</ArticleId></ArticleIdList></Reference><Reference><Citation>Deshpande D., Higelin J., Schoen M., Vomhof T., Boeckers T.M., Demestre M., Michaelis J., Vance C. Synaptic FUS Localization During Motoneuron Development and Its Accumulation in Human ALS Synapses. Front. Cell. Neurosci. 2019;13:256. doi: 10.3389/fncel.2019.00256.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2019.00256</ArticleId><ArticleId IdType="pmc">PMC6582137</ArticleId><ArticleId IdType="pubmed">31244613</ArticleId></ArticleIdList></Reference><Reference><Citation>Zholudeva L.V., Qiang L., Marchenko V., Dougherty K.J., Sakiyama-elbert S.E., Lane M.A., Stop C. The Neuroplastic and Therapeutic Potential of Spinal Interneurons in the Injured Spinal Cord. Trends Neurosci. 2018;41:625&#x2013;639. doi: 10.1016/j.tins.2018.06.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tins.2018.06.004</ArticleId><ArticleId IdType="pmc">PMC6109421</ArticleId><ArticleId IdType="pubmed">30017476</ArticleId></ArticleIdList></Reference><Reference><Citation>Sengottuvel V., Leibinger M., Pfreimer M., Andreadaki A., Fischer D. Taxol Facilitates Axon Regeneration in the Mature CNS. J. Neurosci. 2011;31:2688&#x2013;2699. doi: 10.1523/JNEUROSCI.4885-10.2011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.4885-10.2011</ArticleId><ArticleId IdType="pmc">PMC6623712</ArticleId><ArticleId IdType="pubmed">21325537</ArticleId></ArticleIdList></Reference><Reference><Citation>Rivieccio M.A., Brochier C., Willis D.E., Walker B.A., D&#x2019;Annibale M.A., McLaughlin K., Siddiq A., Kozikowski A.P., Jaffrey S.R., Twiss J.L., et al. HDAC6 Is a Target for Protection and Regeneration Following Injury in the Nervous System. Proc. Natl. Acad. Sci. USA. 2009;106:19599&#x2013;19604. doi: 10.1073/pnas.0907935106.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0907935106</ArticleId><ArticleId IdType="pmc">PMC2780768</ArticleId><ArticleId IdType="pubmed">19884510</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo W., Ludo V.D.B. Therapeutic Potential of HDAC6 in Amyotrophic Lateral Sclerosis. Cell Stress. 2017;2:14&#x2013;16. doi: 10.15698/cst2018.01.120.</Citation><ArticleIdList><ArticleId IdType="doi">10.15698/cst2018.01.120</ArticleId><ArticleId IdType="pmc">PMC6551843</ArticleId><ArticleId IdType="pubmed">31225447</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim H., Binder L.I., Rosenbaum J.L. The Periodic Association of MAP2 with Brain Microtubules in Vitro. J. Cell Biol. 1979;80:266&#x2013;276. doi: 10.1083/jcb.80.2.266.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.80.2.266</ArticleId><ArticleId IdType="pmc">PMC2110341</ArticleId><ArticleId IdType="pubmed">457745</ArticleId></ArticleIdList></Reference><Reference><Citation>Balabanian L., Berger C.L., Hendricks A.G. Acetylated Microtubules Are Preferentially Bundled Leading to Enhanced Kinesin-1 Motility. Biophys. J. 2017;113:1551&#x2013;1560. doi: 10.1016/j.bpj.2017.08.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bpj.2017.08.009</ArticleId><ArticleId IdType="pmc">PMC5627185</ArticleId><ArticleId IdType="pubmed">28978447</ArticleId></ArticleIdList></Reference><Reference><Citation>Garone M.G., Birsa N., Rosito M., Salaris F., Mochi M., de Turris V., Nair R.R., Cunningham T.J., Fisher E.M.C., Morlando M., et al. ALS-Related FUS Mutations Alter Axon Growth in Motoneurons and Affect HuD/ELAVL4 and FMRP Activity. Commun. Biol. 2021;4:1025. doi: 10.1038/s42003-021-02538-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s42003-021-02538-8</ArticleId><ArticleId IdType="pmc">PMC8410767</ArticleId><ArticleId IdType="pubmed">34471224</ArticleId></ArticleIdList></Reference><Reference><Citation>Akiyama T., Suzuki N., Ishikawa M., Fujimori K., Sone T., Kawada J., Funayama R., Fujishima F., Mitsuzawa S., Ikeda K., et al. Aberrant Axon Branching via Fos-B Dysregulation in FUS-ALS Motor Neurons. eBioMedicine. 2019;45:362&#x2013;378. doi: 10.1016/j.ebiom.2019.06.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2019.06.013</ArticleId><ArticleId IdType="pmc">PMC6642224</ArticleId><ArticleId IdType="pubmed">31262712</ArticleId></ArticleIdList></Reference><Reference><Citation>Osking Z., Ayers J.I., Hildebrandt R., Skruber K., Brown H., Ryu D., Eukovich A.R., Golde T.E., Borchelt D.R., Read T.-A., et al. ALS-Linked SOD1 Mutants Enhance Neurite Outgrowth and Branching in Adult Motor Neurons. iScience. 2019;11:294&#x2013;304. doi: 10.1016/j.isci.2018.12.026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.isci.2018.12.026</ArticleId><ArticleId IdType="pmc">PMC6327879</ArticleId><ArticleId IdType="pubmed">30639851</ArticleId></ArticleIdList></Reference><Reference><Citation>Marshall K.L., Rajbhandari L., Venkatesan A., Maragakis N.J., Farah M.H. Enhanced Axonal Regeneration of ALS Patient IPSC-Derived Motor Neurons Harboring SOD1(A4V) Mutation. Sci. Rep. 2023;13:5597. doi: 10.1038/s41598-023-31720-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-023-31720-7</ArticleId><ArticleId IdType="pmc">PMC10076424</ArticleId><ArticleId IdType="pubmed">37020097</ArticleId></ArticleIdList></Reference><Reference><Citation>McWhorter M.L., Monani U.R., Burghes A.H.M., Beattie C.E. Knockdown of the Survival Motor Neuron (Smn) Protein in Zebrafish Causes Defects in Motor Axon Outgrowth and Pathfinding. J. Cell Biol. 2003;162:919&#x2013;931. doi: 10.1083/jcb.200303168.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.200303168</ArticleId><ArticleId IdType="pmc">PMC1761110</ArticleId><ArticleId IdType="pubmed">12952942</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>